Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease

Brain

Volumn 139, Issue 4, 2016, Pages 1189-1199

  Latreille, Véronique ^a,b   Carrier, Julie ^a,b   Gaudet Fex, Benjamin ^a,b   Rodrigues Brazète, Jessica ^a,b   Panisset, Michel ^c   Chouinard, Sylvain ^c   Postuma, Ronald B ^a,d   Gagnon, Jean François ^a,e  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

dementia; electroencephalography; Parkinson's disease; sleep; wakefulness

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; LEVODOPA;

ADULT; AGED; ALPHA RHYTHM; AREA UNDER THE CURVE; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DELTA RHYTHM; DEMENTIA; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONREM SLEEP; OCCIPITAL CORTEX; PARIETAL CORTEX; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REM SLEEP; RESTING STATE NETWORK; SLEEP QUALITY; SLEEP SPINDLE; SLEEP TIME; SLOW WAVE SLEEP; TEMPORAL CORTEX; THETA RHYTHM; WAKEFULNESS; CONSCIOUSNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; TRENDS;

AGED; CONSCIOUSNESS; DEMENTIA; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; WAKEFULNESS;

EID: 84964520997     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aww018     Document Type: Article

References (50)

1. American Academy of Sleep Medicine, Task Force Chair; Hauri PJ. The International classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester IL: American Academy of Sleep Medicine; 2005.
2. Anang JB, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, et al. Predictors of dementia in Parkinson's disease: a prospective cohort study. Neurology 2014; 83: 1253-60.
3. Babiloni C, De Pandis MF, Vecchio F, Buffo P, Sorpresi F, Frisoni GB, et al. Cortical sources of resting state electroencephalographic rhythms in Parkinson's disease related dementia and Alzheimer's disease. Clin Neurophysiol 2011; 122: 2355-64.
4. Beck AT, Epstein N, Brown G, Steer RA An inventory for measuring clinical anxiety: psychometric properties. J. Consult Clin Psychol 1988; 56: 893-7.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
6. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 1995; 57: 289-300.
7. Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behav Brain Res 2011; 221: 564-73.
8. Bonanni L, Perfetti B, Bifolchetti S, Taylor JP, Franciotti R, Parnetti L, et al. Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies. Neurobiol Aging 2015; 36: 434-45.
9. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodiesand Parkinson's disease with dementia patients with a 2-year follow-up. Brain 2008; 131: 690-705.
10. Bousleiman H, Zimmermann R, Ahmed S, Hardmeier M, Hatz F, Schindler C, et al. Power spectra for screening parkinsonian patients for mild cognitive impairment. Ann Clin Transl Neurol 2014; 1: 884-90.
11. Brayet P, Petit D, Frauscher B, Gagnon JF, Gosselin N, Gagnon K, et al. Quantitative EEG of rapid-eye-movement sleep: a marker of amnestic mild cognitive impairment. Clin EEG Neurosci 2015, doi:10.1177/1550059415603050.
12. Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, et al. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease. J Parkinson's Dis 2015; 5: 117-24.
13. Caviness JN, Hentz JG, Evidente VG, Driver-Dunckley ED, Samanta J, Mahant P, et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 348-54.
14. Christensen JA, Kempfner J, Zoetmulder M, Leonthin HL, Arvastson L, Christensen SR, et al. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson's disease. Clin Neurophysiol 2014; 125: 512-19.
15. Christensen JA, Nokolic M, Warby SC, Koch H, Zoetmulder M, Frandsen R, et al. Sleep spindle alterations in patients with Parkinson's disease. Front Hum Neurosci 2015; 9: 233, doi:10.3389/fnhum.2015.00233.
16. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 2007; 22: 2314-24.
17. Fahn S, Elton RL. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent development in Parkinson's disease, Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987. p. 153-63.
18. Fereshtehnejad SM, Romenets SR, Anang JN, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 2015; 72: 863-73.
19. Fogel SM, Smith CT. The function of the sleep spindle: a physiological index of intelligence and a mechanism for sleep-dependent memory consolidation. Neurosci Biobehav Rev 2011; 35: 1154-65.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12: 189-98.
21. Francis PT, Perry EK. Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and Dementia with Lewy bodies. Mov Disord 2007; 22: 351-7.
22. Gratwicke J, Jahanshahi M, Foltynie T. Parkinson's disease dementia: a neural networks perspective. Brain 2015; 138: 1454-76.
23. Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, et al. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain 2014; 137: 2491-508.
24. Han CX, Wang J, Yi GS, Che YQ. Investigation of EEG abnormalities in the early stage of Parkinson's disease. Cogn Neurodyn 2013; 7: 351-9.
25. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-44.
26. Hobson JA, Pace-Schott EF. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 2002; 3: 679-93.
27. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-42.
28. Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012; 27: 8-30.
29. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010; 9: 1200-13.
30. Klassen BT, Hentz JG, Shill HA, Driver-Dunckley E, Evidente VGH, Sabbagh MN, et al. Quantitative EEG as a predictive biomarker for Parkinson disease dementia. Neurology 2011; 77: 1-7.
31. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992; 42: 1371-4.
32. Latreille V, Carrier J, Lafortune M, Postuma RB, Bertrand JA, Panisset M, et al. Sleep spindles in Parkinson's disease may predict the development of dementia. Neurobiol Aging 2015; 36: 1083-90.
33. Litvan I, Goldman JG, Trö ster AI, Schmand BA, Weintraub D, Peterson RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012; 27: 349-56.
34. Liu AK, Chang RC, Pearce RK, Gentleman SM. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Acta Neuropathol 2015; 129: 527-40.
35. Luckhaus C, Grass-Kapanke Blaeser I, Ihl R, Supprian T, Winterer G, et al. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Int J Geriatr Psychiatry 2008; 23: 1148-55.
36. Margis R, Schö nwald SV, Carvalho DZ, Gerhardt GJ, Rieder CR. NREM sleep alpha and sigma activity in Parkinson's disease: evidence for conflicting electrophysiological activity? Clin Neurophysiol 2015; 126: 951-8.
37. McCarley RW. Neurobiology of REM and NREM sleep. Sleep Med 2007; 8: 302-30.
38. Menke RA, Szewczyk-Krolikowski K, Jbabdi S, Jenkinson M, Talbot K, Mackay CE, et al. Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease. Hum Brain Mapp 2014; 35: 1681-90.
39. Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, et al. Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 2010; 25: 2044-51.
40. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am Geriatr Soc 2005; 53: 695-9.
41. Petit D, Lorrain D, Gauthier S, Montplaisir J. Regional spectral analysis of the REM sleep EEG in mild to moderate Alzheimer's disease. Neurobiol Aging 1993; 14: 141-5.
42. Platt B, Riedel G. The cholinergic system, EEG and sleep. Behav Brain Res 2011; 221: 499-504.
43. Poil SS, de Haan W, Van der Flier W, Mansvelder HD, Scheltens P, Linkenkaer-Hansen K. Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage. Front Aging Neurosci 2013; 5: 1-12.
44. Rauchs G, Schabus M, Parapatics S, Bertran F, Clochon P, Hot P, et al. Is there a link between sleep changes and memory in Alzheimer's disease? Neuroreport 2008; 19: 1159-62.
45. Schlede N, Zimmermann R, Ehrensperger MM, Gschwandtner U, Hardmeier M, Hatz F, et al. Clinical EEG in cognitively impaired patients with Parkinson's disease. J. Neurol Sci 2011; 310: 75-8.
46. Serizawa K, Kamei S, Morita A, Hara M, Mizutani T, Yoshihashi H, et al. Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls. J Clin Neurophysiol 2008; 25: 361-6.
47. Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012; 11: 697-707.
48. Westerberg CE, Mander BA, Florczak SM, Weintraub S, Mesulam MM, Zee PC, et al. Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J Int Neuropsychol Soc 2012; 18: 490-500.
49. Wetter TC, Brunner H, Hö gl B, Yassouridis A, Trenkwalder C, Friess E. Increased alpha activity in REM sleep in de novo patients with Parkinson's disease. Mov Disord 2001; 15: 928-33.
50. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132: 2958-69.